Repurposing terfenadine and domperidone for inhibition of apoptotic gene association in colorectal cancer: A system pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis
Bioinformatics and Biology Insights · 2025-08 · 19
DOI: 10.1177/11779322251365019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioinformatics and Biology Insights, online erschienen am 22.08.2025. Verfasst von Pushpaveni C und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, KLE College of Pharmacy, Rajajinagar, Bengaluru and KLE Academy of Higher Education and Research, Belagavi Ka…. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) remains a leading cause of global cancer mortality, underscoring the need for novel therapeutic strategies. This study used a systems pharmacology approach integrated with molecular docking and molecular dynamics (MD) simulations to evaluate the potential of repurposing terfenadine and domperidone for inhibition of apoptotic gene associations in CRC. Network pharmacology analysis identified 4 principal targets—SLC6A4 (5I6X), DRD2 (7DFP), HTR2A (6WGT), and EGFR (6LUD)—involved in the apoptotic regulatory network. Molecular docking studies demonstrated high binding affinities of both terfenadine and domperidone against all selected targets (−7.1 to −11.5 kcal/mol), with the strongest interaction observed with DRD2, where both compounds exhibited a binding affinity of −11.5 kcal/mol. Detailed interaction profiling revealed critical hydrogen bonding and hydrophobic interactions stabilizing the drug-target complexes. Molecular dynamics simulations over a 100 ns timescale confirmed the structural stability and conformational fidelity of the docked complexes, evidenced by low root mean square deviation values and consistent hydrogen bond occupancy. Furthermore, post-MD simulation study supports the stable score landscape and stability of complex. In conclusion, this integrative computational analysis highlights terfenadine and domperidone as promising candidates capable of modulating key apoptotic pathways in CRC. The findings provide a strong rationale for subsequent in vitro and in vivo studies to validate their therapeutic potential and facilitate clinical translation in CRC management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, KLE College of Pharmacy, Rajajinagar, Bengaluru and KLE Academy of Higher Education and Research, Belagavi Karnataka, India.
- Department of Pharmaceutical chemistry, Institute of Pharmacy PES University, Electronic city campus, Hosur Road Bengaluru, Karnataka, India.
- Department of Pharmacology, East Point College of Pharmacy, Bengaluru, India.
- Department of Pharmacy, Universal College of Medical Sciences, Bhairahawa, Nepal.
- Department of Pharmaceutical Analysis, Institute of Pharmacy, PES University, Bengaluru, India.
- Department of Pharmaceutical Chemistry, Al-Ameen College of Pharmacy, Bengaluru, India.
ORCID-Profile: Pushpaveni C, Santosh Prasad Chaudhary Kurmi, Shankar Thapa
Zitieren
APA
C, P., S, H., Kurmi, S. P. C., Patra, B. R., Esther, V. A., Yadav, C. K., Biradar, M. S., & Thapa, S. (2025). Repurposing terfenadine and domperidone for inhibition of apoptotic gene association in colorectal cancer: A system pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis. Bioinformatics and Biology Insights, 19. https://doi.org/10.1177/11779322251365019
Vancouver
C P, S H, Kurmi SPC, Patra BR, Esther VA, Yadav CK, et al. Repurposing terfenadine and domperidone for inhibition of apoptotic gene association in colorectal cancer: A system pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis. Bioinformatics and Biology Insights. 2025;19. doi:10.1177/11779322251365019
BibTeX
@article{C2025,
author = {C, Pushpaveni and S, Hemavathi and Kurmi, Santosh Prasad Chaudhary and Patra, Biswa Ranjan and Esther, V Angelin and Yadav, Chandrajeet Kumar and Biradar, Mahalakshmi Suresha and Thapa, Shankar},
title = {Repurposing terfenadine and domperidone for inhibition of apoptotic gene association in colorectal cancer: A system pharmacology approach integrated with molecular docking, MD simulations, and post-MD simulation analysis},
journal = {Bioinformatics and Biology Insights},
year = {2025},
volume = {19},
doi = {10.1177/11779322251365019}
}
EUVIMED